טוען...
TRANSPLANTATION: Complementing donor-specific antibody testing
New data suggests that among kidney transplant recipients, those whose serum contains donor-specific antibodies that bind C1q fare the worst. Although these findings are intriguing, several unanswered questions remain. Changing practice to include a C1q binding assay as standard of care in kidney tr...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4090765/ https://ncbi.nlm.nih.gov/pubmed/24189651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneph.2013.234 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|